v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating Expenses [Abstract]        
Research and development $ 16,172 $ 6,997 $ 29,570 $ 14,654
General and administrative 7,205 2,735 13,805 5,850
Total operating expenses 23,377 9,732 43,375 20,504
Loss from operations (23,377) (9,732) (43,375) (20,504)
Changes in fair value of warrant liabilities (1,111) (627) (1,593) 4,409
Interest expense (62) (64) (125) (134)
Interest income 1,709 14 2,756 76
Other income, net 350 295 977 842
Total other income (expense) 886 (382) 2,015 5,193
Net loss (22,491) (10,114) (41,360) (15,311)
Other comprehensive income (loss):        
Unrealized loss, change in fair value of available-for-sale securities (717) 0 (1,217) (1)
Reclassification adjustment for gain on sale of available-for-sale securities included in net income 0 0 (47) 0
Foreign currency translation gain 10 95 147 120
Total comprehensive loss $ (23,198) $ (10,019) $ (42,477) $ (15,192)
Loss per common share attributable to the Company's shareholders        
Basic loss per common share $ (0.28) $ (1.09) $ (0.62) $ (1.65)
Diluted loss per common share $ (0.28) $ (1.09) $ (0.62) $ (1.65)
Weighted-average common shares outstanding - basic 79,753,100 9,294,469 66,768,309 9,293,018
Weighted-average common shares outstanding - diluted 79,753,100 9,294,469 66,768,309 9,293,018